Gene · 5166
Papers3,136
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,136
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of urinary extracellular vesicles from prostate cancer patients on the transcriptomes of cancer-associated and normal fibroblasts. | BMC Cancer | 2022 | 36224527 | PubTator, text mining | PubMed |
| The Beneficial Effects of Geniposide on Glucose and Lipid Metabolism: A Review. | Drug Des Devel Ther | 2022 | 36213380 | PubTator, text mining | PubMed |
| Pan-cancer analysis of cuproptosis regulation patterns and identification of mTOR-target responder in clear cell renal cell carcinoma. | Biol Direct | 2022 | 36209249 | PubTator, text mining | PubMed |
| The Variation of Transcriptomic Perturbations is Associated with the Development and Progression of Various Diseases. | Dis Markers | 2022 | 36204511 | PubTator, text mining | PubMed |
| Bioinformatics and network-based screening and discovery of potential molecular targets and small molecular drugs for breast cancer. | Front Pharmacol | 2022 | 36204232 | PubTator, text mining | PubMed |
| Can genetics guide exercise prescriptions in osteoarthritis? | Front Rehabil Sci | 2022 | 36188938 | PubTator, text mining | PubMed |
| A transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma. | Nat Commun | 2022 | 36180422 | PubTator, text mining | PubMed |
| Lactic acid bacteria-derived γ-linolenic acid metabolites are PPARδ ligands that reduce lipid accumulation in human intestinal organoids. | J Biol Chem | 2022 | 36162507 | PubTator, text mining | PubMed |
| Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios. | World J Gastroenterol | 2022 | 36161051 | PubTator, text mining | PubMed |
| Effects of cyclic acute and chronic hypoxia on the expression levels of metabolism related genes in a pancreatic cancer cell line. | Biomed Rep | 2022 | 36158320 | PubTator, text mining | PubMed |
| Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma. | Cell Death Dis | 2022 | 36151074 | PubTator, text mining | PubMed |
| Comprehensive analysis and validation of novel immune and vascular remodeling related genes signature associated with drug interactions in pulmonary arterial hypertension. | Front Genet | 2022 | 36147486 | PubTator, text mining | PubMed |
| m7G regulator-mediated molecular subtypes and tumor microenvironment in kidney renal clear cell carcinoma. | Front Pharmacol | 2022 | 36147333 | PubTator, text mining | PubMed |
| From Diabetes Care to Heart Failure Management: A Potential Therapeutic Approach Combining SGLT2 Inhibitors and Plant Extracts. | Nutrients | 2022 | 36145112 | PubTator, text mining | PubMed |
| Demystifying the Functional Role of Nuclear Receptors in Esophageal Cancer. | Int J Mol Sci | 2022 | 36142861 | PubTator, text mining | PubMed |
| A Novel L-Phenylalanine Dipeptide Inhibits the Growth and Metastasis of Prostate Cancer Cells via Targeting DUSP1 and TNFSF9. | Int J Mol Sci | 2022 | 36142828 | PubTator, text mining | PubMed |
| Disturbed Cardiac Metabolism Triggers Atrial Arrhythmogenesis in Diabetes Mellitus: Energy Substrate Alternate as a Potential Therapeutic Intervention. | Cells | 2022 | 36139490 | PubTator, text mining | PubMed |
| Human alpha cell transcriptomic signatures of types 1 and 2 diabetes highlight disease-specific dysfunction pathways. | iScience | 2022 | 36134336 | PubTator, text mining | PubMed |
| Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis. | Front Endocrinol (Lausanne) | 2022 | 36120471 | PubTator, text mining | PubMed |
| Roles of long noncoding RNAs and small extracellular vesicle-long noncoding RNAs in type 2 diabetes. | Traffic | 2022 | 36109347 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5166/papers?page=38